434 related articles for article (PubMed ID: 32591530)
1. Systemic nanoparticle delivery of CRISPR-Cas9 ribonucleoproteins for effective tissue specific genome editing.
Wei T; Cheng Q; Min YL; Olson EN; Siegwart DJ
Nat Commun; 2020 Jun; 11(1):3232. PubMed ID: 32591530
[TBL] [Abstract][Full Text] [Related]
2. Genome editing in the mouse brain with minimally immunogenic Cas9 RNPs.
Stahl EC; Sabo JK; Kang MH; Allen R; Applegate E; Kim SE; Kwon Y; Seth A; Lemus N; Salinas-Rios V; Soczek KM; Trinidad M; Vo LT; Jeans C; Wozniak A; Morris T; Kimberlin A; Foti T; Savage DF; Doudna JA
Mol Ther; 2023 Aug; 31(8):2422-2438. PubMed ID: 37403358
[TBL] [Abstract][Full Text] [Related]
3. A Single Administration of CRISPR/Cas9 Lipid Nanoparticles Achieves Robust and Persistent In Vivo Genome Editing.
Finn JD; Smith AR; Patel MC; Shaw L; Youniss MR; van Heteren J; Dirstine T; Ciullo C; Lescarbeau R; Seitzer J; Shah RR; Shah A; Ling D; Growe J; Pink M; Rohde E; Wood KM; Salomon WE; Harrington WF; Dombrowski C; Strapps WR; Chang Y; Morrissey DV
Cell Rep; 2018 Feb; 22(9):2227-2235. PubMed ID: 29490262
[TBL] [Abstract][Full Text] [Related]
4. CRISPR/Cas9 ribonucleoprotein-mediated genome and epigenome editing in mammalian cells.
Bloomer H; Khirallah J; Li Y; Xu Q
Adv Drug Deliv Rev; 2022 Feb; 181():114087. PubMed ID: 34942274
[TBL] [Abstract][Full Text] [Related]
5. A Guanidinobenzol-Rich Polymer Overcoming Cascade Delivery Barriers for CRISPR-Cas9 Genome Editing.
Liang S; Ma N; Li X; Yun K; Meng QF; Ma K; Yue L; Rao L; Chen X; Wang Z
Nano Lett; 2024 Jun; 24(23):6872-6880. PubMed ID: 38683656
[TBL] [Abstract][Full Text] [Related]
6. Engineering self-deliverable ribonucleoproteins for genome editing in the brain.
Chen K; Stahl EC; Kang MH; Xu B; Allen R; Trinidad M; Doudna JA
Nat Commun; 2024 Feb; 15(1):1727. PubMed ID: 38409124
[TBL] [Abstract][Full Text] [Related]
7. Intracellular delivery and biodistribution study of CRISPR/Cas9 ribonucleoprotein loaded bioreducible lipidoid nanoparticles.
Li Y; Bolinger J; Yu Y; Glass Z; Shi N; Yang L; Wang M; Xu Q
Biomater Sci; 2019 Jan; 7(2):596-606. PubMed ID: 30062347
[TBL] [Abstract][Full Text] [Related]
8. Lipo-Xenopeptide Polyplexes for CRISPR/Cas9 based Gene editing at ultra-low dose.
Germer J; Lessl AL; Pöhmerer J; Grau M; Weidinger E; Höhn M; Yazdi M; Cappelluti MA; Lombardo A; Lächelt U; Wagner E
J Control Release; 2024 Jun; 370():239-255. PubMed ID: 38663751
[TBL] [Abstract][Full Text] [Related]
9. Biomimetic Mineralization-Based CRISPR/Cas9 Ribonucleoprotein Nanoparticles for Gene Editing.
Li S; Song Z; Liu C; Chen XL; Han H
ACS Appl Mater Interfaces; 2019 Dec; 11(51):47762-47770. PubMed ID: 31773942
[TBL] [Abstract][Full Text] [Related]
10. Cationic Polymer-Mediated CRISPR/Cas9 Plasmid Delivery for Genome Editing.
Zhang Z; Wan T; Chen Y; Chen Y; Sun H; Cao T; Songyang Z; Tang G; Wu C; Ping Y; Xu FJ; Huang J
Macromol Rapid Commun; 2019 Mar; 40(5):e1800068. PubMed ID: 29708298
[TBL] [Abstract][Full Text] [Related]
11. Non-Viral CRISPR/Cas Gene Editing In Vitro and In Vivo Enabled by Synthetic Nanoparticle Co-Delivery of Cas9 mRNA and sgRNA.
Miller JB; Zhang S; Kos P; Xiong H; Zhou K; Perelman SS; Zhu H; Siegwart DJ
Angew Chem Int Ed Engl; 2017 Jan; 56(4):1059-1063. PubMed ID: 27981708
[TBL] [Abstract][Full Text] [Related]
12. Direct Cytosolic Delivery of CRISPR/Cas9-Ribonucleoprotein for Efficient Gene Editing.
Mout R; Ray M; Yesilbag Tonga G; Lee YW; Tay T; Sasaki K; Rotello VM
ACS Nano; 2017 Mar; 11(3):2452-2458. PubMed ID: 28129503
[TBL] [Abstract][Full Text] [Related]
13. Methods for CRISPR-Cas as Ribonucleoprotein Complex Delivery In Vivo.
Bykonya AG; Lavrov AV; Smirnikhina SA
Mol Biotechnol; 2023 Feb; 65(2):181-195. PubMed ID: 35322386
[TBL] [Abstract][Full Text] [Related]
14. Delivering Cas9/sgRNA ribonucleoprotein (RNP) by lentiviral capsid-based bionanoparticles for efficient 'hit-and-run' genome editing.
Lyu P; Javidi-Parsijani P; Atala A; Lu B
Nucleic Acids Res; 2019 Sep; 47(17):e99. PubMed ID: 31299082
[TBL] [Abstract][Full Text] [Related]
15. A pipeline for precise and efficient genome editing by sgRNA-Cas9 RNPs in
Nyberg KG; Nguyen JQ; Kwon YJ; Blythe S; Beitel GJ; Carthew R
Fly (Austin); 2020; 14(1-4):34-48. PubMed ID: 33016195
[TBL] [Abstract][Full Text] [Related]
16. Smart arginine-equipped polycationic nanoparticles for p/CRISPR delivery into cells.
Moradi P; Hasanzadeh A; Radmanesh F; Rajai Daryasarei S; Hosseini ES; Kiani J; Shahbazi A; Nourizadeh H; Eslami M; Dorgalaleh A; Sahlolbei M; Hamblin MR; Karimi M
Nanotechnology; 2021 Nov; 33(7):. PubMed ID: 34727527
[TBL] [Abstract][Full Text] [Related]
17. Methods for CRISPR/Cas9 Xenopus tropicalis Tissue-Specific Multiplex Genome Engineering.
Naert T; Vleminckx K
Methods Mol Biol; 2018; 1865():33-54. PubMed ID: 30151757
[TBL] [Abstract][Full Text] [Related]
18. LNP-mediated delivery of CRISPR RNP for wide-spread in vivo genome editing in mouse cornea.
Mirjalili Mohanna SZ; Djaksigulova D; Hill AM; Wagner PK; Simpson EM; Leavitt BR
J Control Release; 2022 Oct; 350():401-413. PubMed ID: 36029893
[TBL] [Abstract][Full Text] [Related]
19. A carrier-free multiplexed gene editing system applicable for suspension cells.
Ju A; Lee SW; Lee YE; Han KC; Kim JC; Shin SC; Park HJ; EunKyeong Kim E; Hong S; Jang M
Biomaterials; 2019 Oct; 217():119298. PubMed ID: 31280073
[TBL] [Abstract][Full Text] [Related]
20. Carboxylated nanodiamond-mediated CRISPR-Cas9 delivery of human retinoschisis mutation into human iPSCs and mouse retina.
Yang TC; Chang CY; Yarmishyn AA; Mao YS; Yang YP; Wang ML; Hsu CC; Yang HY; Hwang DK; Chen SJ; Tsai ML; Lai YH; Tzeng Y; Chang CC; Chiou SH
Acta Biomater; 2020 Jan; 101():484-494. PubMed ID: 31672582
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
